As the respiratory illness season begins, cases of respiratory syncytial virus (RSV) cases are rising in Canada. But new tools offers hope for prevention.

Most positive tests for RSV so far this season in Canada have been among the youngest, federal data suggests. And while ...

In a new study, the RSV drug nirsevimab was 93% effective at preventing young children from being hospitalized for the ...

The respiratory syncytial virus (RSV) prophylaxis market across the eight major markets (8MM; USA, France, Germany, Italy.

Months Before C.E.O.’s Killing, the Suspect Went Silent. Where Was He? New details are emerging about Luigi Mangione’s growing impatience with “a capitalist society” and his search for ...

Pharmac has announced that, from January 1 2025, it will fund palivizumab - a medicine that prevents serious illness from ...

High levels of neutralizing antibodies to RSV F protein have been shown to correlate with protection from RSV disease in infants and the elderly, and the clinical effectiveness of palivizumab and ...

Thanks to the introduction of new monoclonal antibodies and vaccines. The respiratory syncytial virus (RSV) prophylaxis ...

The government's drug funding agency Pharmac is asking for public feedback on its proposal to fund four new medicines for ...

South Africa sweep Sri Lanka 2-0 to lead World Test Championship table Maharaj’s five-for helps South Africa beat Sri Lanka by 109 runs and leap ahead of Australia and India on the WTC table ...

Following public consultation, from 1 January 2025 Pharmac will fund: osimertinib (branded as Tagrisso) for people with a type of advanced non-small cell lung cancer trastuzumab deruxtecan (branded as ...